ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32475-5mg |
|
— |
MM 07
|
0 | — | |
GC32475-1mg |
|
— |
MM 07
|
0 | — | |
GC32475-10mM(1mLinDMSO) |
|
— |
MM 07
|
0 | — | |
GC32473-100mg |
|
1438492-26-2 |
Ciraparantag (PER977)
|
0 | C22H48N12O2 | |
GC32473-50mg |
|
1438492-26-2 |
Ciraparantag (PER977)
|
0 | C22H48N12O2 | |
GC32473-5mg |
|
1438492-26-2 |
Ciraparantag (PER977)
|
0 | C22H48N12O2 | |
GC32473-1mg |
|
1438492-26-2 |
Ciraparantag (PER977)
|
0 | C22H48N12O2 | |
GC32473-10mM(1mLinWater) |
|
1438492-26-2 |
Ciraparantag (PER977)
|
0 | C22H48N12O2 | |
GC32472-100mg |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32472-50mg |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32472-10mg |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32472-5mg |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32472-2mg |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32472-10mM(1mLinDMSO) |
|
1350653-20-1 |
Vericiguat (BAY1021189)
|
0 | C19H16F2N8O2 | |
GC32471-100mg |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |
GC32471-50mg |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |
GC32471-10mg |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |
GC32471-5mg |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |
GC32471-1mg |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |
GC32471-10mM(1mLinDMSO) |
|
1629249-40-6 |
GSK 3008348 hydrochloride
|
0 | C29H37N5O2.xHCl | |